Boyan Vesselinov Litchev is Chief Medical Officer of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 1,150 shares of INDP, which is worth approximately $1,656. The most recent transaction as insider was on Dec 01, 2022, when has been sold 500 shares (Common Stock) at a price of $1.87 per share, resulting in proceeds of $935. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15K
0% 3M change
0% 12M change
Total Value Held $1,656

Boyan Vesselinov Litchev Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2022
BUY
Open market or private purchase
$935 $1.87 p/Share
500 Added 30.3%
1,150 Common Stock
Nov 22 2022
BUY
Open market or private purchase
$915 $1.83 p/Share
500 Added 43.48%
650 Common Stock
Mar 02 2022
BUY
Open market or private purchase
$204 $4.09 p/Share
50 Added 25.0%
150 Common Stock
Jan 31 2022
BUY
Open market or private purchase
$465 $4.65 p/Share
100 Added 50.0%
100 Common Stock
BVL

Boyan Vesselinov Litchev

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if

News

Receive news related to Indaptus Therapeutics, Inc.

Track Activities on INDP